Cancer-related Pain Management A Report of Evidence-based Recommendations to Guide Practice

Nursing and Psychosocial Oncology, Cancer Care Ontario, Toronto, ON, Canada.
The Clinical journal of pain (Impact Factor: 2.53). 07/2010; 26(6):449-62. DOI: 10.1097/AJP.0b013e3181dacd62
Source: PubMed

ABSTRACT Cancer may be associated with many symptoms, but pain is the one most feared by patients. Pain is experienced by one-third of patients receiving treatment for cancer and about two-thirds of those with advanced cancers. To aid in providing quality care and pain relief for cancer patients, Cancer Care Ontario's Cancer-related Pain Management Guideline Panel conducted a systematic review of guidelines to provide evidence-based and consensus recommendations for the management of cancer-related pain to guide the practice of healthcare providers.
Published and unpublished cancer-related pain management guidelines were sought by conducting an Internet search, which included health organizations and the National Guidelines Clearinghouse, the Guideline International Network, and the McMillan Group. Also, MEDLINE searches were conducted for guidelines published between the years 2000 and May 2006.
Twenty-five guidelines were found and the quality of each guideline was evaluated using the Appraisal of Guideline Research and Evaluation Instrument and the utility of the guideline for recommendations was assessed. Using these 2 criteria, 8 relevant and high-quality pain guidelines were identified. From these guidelines, the Panel articulated core principles of the management of cancer pain and selected or adapted specific recommendations through consensus to become a part of the cancer-related pain guide for practice.
The domains on which recommendations were drafted include: assessment of pain; assessors of pain; time and frequency of assessment; components of pain assessment; assessment of pain in special populations; plan of care; pharmacologic intervention; nonpharmacologic intervention; documentation; education; and outcome measures of cancer-pain management.

1 Follower
73 Reads
  • [Show abstract] [Hide abstract]
    ABSTRACT: A common disorder requiring symptom palliation in palliative and end-of-life care is cancer. Cancer pain is recognized as a global health burden. This paper sought to systematically examine the extent to which there is an adequate scientific research base on cancer pain and its reporting characteristics in the palliative care journal literature. Search conducted in MEDLINE and CINAHL sought to locate all studies published in 19 palliative/ hospice/ supportive/ end-of-life care journals from 2009 to 2010. The journals included were: American Journal of Hospice and Palliative Care, BMC Palliative Care, Current Opinion in Supportive and Palliative Care, End of Life Care Journal, European Journal of Palliative Care, Hospice Management Advisor, Indian Journal of Palliative Care, International Journal of Palliative Nursing, Internet Journal of Pain Symptom Control and Palliative Care, Journal of Pain and Palliative Care Pharmacotherapy, Journal of Palliative Care, Journal of Palliative Medicine, Journal of Social Work in End-of-life and Palliative Care, Journal of Supportive Oncology, Palliative Medicine, Palliative and Supportive Care, and Supportive Care in Cancer. Journal contents were searched to identify studies that included cancer pain in abstract. During the years 2009 and 2010, of the selected 1,569 articles published in the journals reviewed, only 5.86% (92 articles) were on cancer pain. While researchers in the field of palliative care have studied cancer pain, the total percentage for studies is still a low 5.86%. To move the field of palliative care forward so that appropriate guidelines for cancer pain management can be developed, it is critical that more research be reported upon which to base cancer pain therapy in an evidence-based palliative care model.
    Indian Journal of Palliative Care 01/2011; 17(1):57-66. DOI:10.4103/0973-1075.78451
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: To describe the current position of educational interventions within the context of cancer pain management. Barriers to good cancer pain control exist within patients and professionals and centre on lack of knowledge or poor attitudes towards pain and opioid analgesia. Education provided to healthcare professionals increases knowledge and improves attitudes but this does not necessarily translate into improvements in patient outcomes. However, targeted interventions that modify professional behaviour are effective. Educational interventions directed at patients result in improved patient outcomes, although the mechanisms by which these improvements occur are not yet clear. Overall, educational interventions directed at patients or professionals can result in significant but modest clinical benefit which is similar in magnitude to that achieved by some analgesics. Educational interventions should be part of routine clinical practice alongside optimal oncological and analgesic management. Further work is needed on how best to implement multicomponent interventions within clinical services, including the identification of which combinations are most cost effective.
    Current opinion in supportive and palliative care 03/2011; 5(1):20-4. DOI:10.1097/SPC.0b013e328342c607 · 1.66 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: In patients with active cancer, the management of chronic pain is an essential element in a comprehensive strategy for palliative care. This strategy emphasises multidimensional assessment and the coordinated use of treatments that together mitigate suffering and provide support to the patient and family. This review describes this framework, an approach to pain assessment, and widely accepted techniques to optimise the safety and effectiveness of opioid drugs and other treatments. The advances of recent decades suggest a future that includes increased evidence-based targeting of specific analgesic interventions within an individualised plan of care that is appropriate throughout the course of illness.
    The Lancet 06/2011; 377(9784):2236-47. DOI:10.1016/S0140-6736(11)60236-5 · 45.22 Impact Factor
Show more


73 Reads
Available from